[Photo/VCG] China's top drug authority said it has been accelerating approval of new drugs researched and developed overseas, and a number of such new drugs will be available for patient use on the Chinese mainland this year. The National Medial Products Administration released a list at the end of last year of 48 overseas new drugs, including 12 cancer drugs, for priority approval, and eight have been available in the domestic market, the administration said, China Central Television reported on Monday. All these drugs are already available in overseas markets, and they are urgently needed by domestic patients, it said. The administration will recognize research data conducted by developers of the drugs overseas, and give approval to the drugs as long as their applicants believe the drugs will not cause different safety risks and effects to peoples of different races, the administration said. Meanwhile, the administration also is improving information exchanges with drug researchers and developers, which has facilitated drug research and development, it said. The administration accepted more than 1,500 requests for exchanges from drug developers, including more than 600 requests from developers of cancer drugs, by Dec 10, it said. China has been simplifying inspection and approval procedures of overseas new drugs so they can be available in China more quickly. The administration would recognize data of clinical trials conducted outside China in the approval of new drugs, according to a guideline released by the administration last year. Previously, such data was not recognized by the administration, so lengthy clinical trials had to be conducted in China again before drugs could be approved, even though they had been available for use overseas for years. This was a cause for delay in the availability of many new drugs in the Chinese market. silicone braceletswristbands for eventsfuck cancer bracelet
A relative shows a picture of Fumio Okubo, who killed himself at the prospect of leaving his home after the Fukushima nuclear plant disaster in 2011. ASIA NEWS NETWORK TOKYO - A Japanese court on Tuesday ordered the operator of the crippled Fukushima nuclear plant to compensate relatives of a 102-year-old man who killed himself at the prospect of fleeing his home. The Fukushima District Court ordered Tokyo Electric Co to pay 15.2 million yen ($143,400) in damages to the family of Fumio Okubo, according to their attorney Yukio Yasuda. Okubo was the oldest resident of Iitate village, 40 kilometers from the tsunami-hit Fukushima Daiichi plant on Japan's northeast coast, which sparked the world's worst atomic accident in a generation in 2011. He took his own life after the government ordered residents to flee in April 2011, a month after tsunami waves sent the plant's reactors into meltdown. I lived a bit too long, he told his family soon after he learned of the government-ordered evacuation from a news report. The court acknowledged his suicide was linked to strong stress at the prospect that he would have to flee and his fear that he would be a burden to his family, the attorney said. It is significant that the court recognised the eldest man in the village who would have lived out his final days in his homeland was hit by such a terrible tragedy, he said. The compensation ordered by the court was smaller than the 60 million yen the family had demanded, but they do not plan to appeal, he added. TEPCO said it would examine the latest ruling before it decides on its response The firm has already been told to pay damages over two other suicides involving former residents who killed themselves after fleeing their homes. Iitate was one of a number of areas the central government declared off-limits due to concerns at the effect of long-term exposure to radiation. The tsunami, triggered by a magnitude-9 earthquake on March 11, 2011, swamped the emergency power supplies at the Fukushima power plant, sending its reactors into meltdown as cooling systems failed. Many of the tens of thousands of people who evacuated their homes and farms are unlikely to return to their ancestral properties due to radiation dangers. While the quake and tsunami killed nearly 18,000 people, no one is officially recorded as having died as a direct result of the atomic catastrophe. Agence France-presse
